Publication: 2148

Publication: 2148

Randomized phase II trial of capecitabine and lapatinib with or without cixutumumab in patients with HER2+ breast cancer previously treated with trastuzumab and an anthracycline and/or a taxane: NCCTG N0733 (Alliance).

URL

Google Scholar

Citation:: J Clin Oncol vol 32 (5s) suppl; abstr 632)

Meeting Instance:: ASCO 2014
Year:: 2014
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 3492

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:

Corr. Author:: Paul Haluska
Authors:: Paul Haluska Albert M. Bernath Karla V. Ballman Amylou C. Dueck Hannah M. Linden Matthew P. Goetz Donald W. Northfelt Xiaonan Hou Kathleen S. Tenner Piyawan Tienchaiananda Lynn M. Flickinger Beiyun Chen Helen X. Chen Wilma L. Lingle Christine M. Pellegrino Robert W. Sponzo Monica Madden Reinholz Edith A. Perez

Networks:

Study: NCCTG-N0733
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: